FilingReader Intelligence
Hualan Biological gets clinical trial approval for Hib vaccine
August 13, 2025 at 08:21 AM UTC•By FilingReader AI
Hualan Biological Engineering announced its subsidiary Hualan Biological Vaccines received National Medical Products Administration approval for clinical trials of its freeze-dried Haemophilus influenzae type b conjugate vaccine.
The vaccine is designed to prevent invasive Hib infections, including meningitis and pneumonia.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Hualan Biological Engineering publishes news
Free account required • Unsubscribe anytime